What it's for (Indications)
- Indapamide is primarily indicated for the treatment of essential hypertension, either as monotherapy or in combination with other antihypertensive agents, particularly in patients who have not achieved adequate blood pressure control with a single agent.
- Its efficacy in reducing systolic and diastolic blood pressure has been well-established through clinical trials.
- Furthermore, indapamide is indicated for the management of edema associated with congestive heart failure.
- In this context, it aids in reducing fluid retention and alleviating symptoms such as dyspnea and peripheral swelling.
- Its long duration of action allows for once-daily dosing, contributing to patient adherence in chronic conditions.
- Prescribing should always follow a thorough assessment of the patient's cardiovascular profile and electrolyte status.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For the treatment of essential hypertension, the usual starting dose of indapamide (e.g., Baplow) is 1.25 mg taken orally once daily in the morning. If the blood pressure response is inadequate after 4-8 weeks, the dose may be increased to 2.5 mg once daily. Doses above 2.5 mg daily generally do not provide additional antihypertensive benefits but may increase the risk of electrolyte disturbances. For the management of edema associated with congestive heart failure, the recommended starting dose is also typically 2.5 mg once daily, administered in the morning. Dosage adjustments should be made based on the patient's clinical response, electrolyte levels, and renal function, always aiming for the lowest effective dose to minimize adverse effects. Administration in the morning helps prevent nocturia, improving patient comfort and sleep quality. |
Safety & Warnings
Common Side Effects
- Common side effects associated with indapamide include headache, dizziness, fatigue, muscle cramps, and gastrointestinal disturbances such as nausea, vomiting, constipation, or diarrhea.
- Electrolyte imbalances are a significant concern, with hypokalemia (low potassium) being particularly prevalent, along with hyponatremia (low sodium), hypomagnesemia (low magnesium), and hypercalcemia (high calcium).
- These electrolyte disturbances can lead to more serious complications, including cardiac arrhythmias.
- Other potential adverse effects include orthostatic hypotension, hyperglycemia (especially in diabetic patients), hyperuricemia (which can precipitate gout attacks), and photosensitivity reactions.
- Rarely, more severe effects such as pancreatitis, blood dyscrasias (e.
- g.
- , thrombocytopenia, leukopenia), and severe skin reactions (e.
- g.
- , Stevens-Johnson syndrome) may occur.
- Regular monitoring of electrolytes, renal function, and blood glucose is crucial.
Serious Warnings
- Black Box Warning: Serious Warnings: Indapamide, similar to other thiazide-like diuretics, carries a significant risk of severe electrolyte disturbances, which can be life-threatening if not promptly managed. These include profound hypokalemia (low potassium), which can lead to potentially fatal cardiac arrhythmias, especially in patients with pre-existing heart conditions, concomitant digitalis therapy, or prolonged QT interval. Severe hyponatremia (low sodium) can also occur, potentially leading to neurological complications such as confusion, seizures, and cerebral edema. Volume depletion resulting from excessive diuresis can cause orthostatic hypotension, dizziness, and syncope, particularly in elderly patients or those on concomitant antihypertensive agents. This can also lead to acute kidney injury due to reduced renal perfusion. Patients with hepatic impairment are at an increased risk of developing hepatic encephalopathy. Strict monitoring of serum electrolytes (potassium, sodium, magnesium, calcium) and renal function (BUN, creatinine) is essential before and periodically throughout therapy, especially in high-risk populations, to prevent and manage these potentially severe adverse events. Clinical judgment is paramount in balancing therapeutic benefits against these significant safety risks.
- Patients receiving indapamide should be closely monitored for signs and symptoms of fluid and electrolyte imbalance, particularly hypokalemia, hyponatremia, and hypochloremic alkalosis, especially during concomitant therapy with digitalis, corticosteroids, or ACTH.
- It should be used with caution in patients with impaired renal function, as thiazide-like diuretics may exacerbate azotemia.
- In patients with hepatic impairment, particularly those with severe disease, minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
- Indapamide may increase blood glucose levels, necessitating careful monitoring in diabetic patients.
- It can also increase serum uric acid, potentially precipitating gout attacks in susceptible individuals.
- Photosensitivity reactions have been reported; patients should be advised to protect skin from sun exposure.
- Caution is also advised in patients with systemic lupus erythematosus, as indapamide may exacerbate or activate the disease.
- Regular blood pressure, renal function, and electrolyte monitoring are essential during treatment.
How it Works (Mechanism of Action)
Indapamide is a sulfonamide derivative and a thiazide-like diuretic that exerts its antihypertensive and diuretic effects primarily by inhibiting sodium reabsorption in the cortical diluting segment of the renal tubules. This action leads to increased excretion of sodium, chloride, and water, thereby reducing plasma volume. Unlike true thiazides, indapamide also possesses direct vascular effects, including a reduction in vascular smooth muscle reactivity to various vasoactive agents, which contributes to its antihypertensive action independent of its diuretic effect. It has been shown to reduce peripheral vascular resistance, likely through mechanisms involving altered calcium handling in vascular smooth muscle cells. This dual mechanism—diuretic action and direct vascular effects—contributes to its overall efficacy in managing hypertension and edema.